Clevenger Marvin Bradford 4
4 · Rocket Lab Corp · Filed May 28, 2026
Research Summary
AI-generated summary of this filing
Rocket Lab (RKLB) President Marvin Clevenger Sells Shares
What Happened
- Marvin Bradford Clevenger, President of Rocket Lab USA, Inc., sold a total of 15,549 Rocket Lab (RKLB) shares in multiple open-market transactions on May 26, 2026, generating approximately $2,216,874. The individual tranches were:
- 411 shares at $139.41 — $57,298
- 1,222 shares at $140.20 — $171,326
- 1,519 shares at $141.46 — $214,872
- 4,524 shares at $142.35 — $644,014
- 6,055 shares at $143.24 — $867,338
- 1,818 shares at $144.13 — $262,026
- These were sales (not purchases). Footnotes indicate the primary reason was a "sell-to-cover" to satisfy tax withholding obligations related to the vesting and settlement of previously granted restricted stock units (RSUs), which is a routine tax-related sale.
Key Details
- Transaction date: May 26, 2026; Form 4 filed May 28, 2026 (timely — within typical 2-business-day window).
- Total shares sold: 15,549; total proceeds: ~$2.22 million.
- Reported price range across all transactions (per footnotes): $138.77 to $144.76; some line items report weighted-average prices for multiple trades within narrower ranges.
- Notable footnotes: F1 — sale was "sell-to-cover" for tax withholding on RSU vesting; F2–F8 — explain weighted-average pricing and per-tranche price ranges; F3 — references 589 shares acquired under the company ESPP (exempt under Rule 16b-3).
- Shares owned after the transaction: not reported in the provided excerpt of the Form 4.
Context
- "Sell-to-cover" sales are common when RSUs vest and are used to pay required taxes; they do not necessarily reflect a change in the insider’s view of the company.
- This filing documents sales (S). For retail investors, purchases typically carry clearer potential signals of insider confidence; routine tax-withholding sales are common and often neutral.
Insider Transaction Report
Form 4
Rocket Lab CorpRKLB
Clevenger Marvin Bradford
President, Rocket Lab USA, Inc
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-05-26$139.41/sh−411$57,298→ 492,613 total - Sale
Common Stock
[F1][F4]2026-05-26$140.20/sh−1,222$171,326→ 491,391 total - Sale
Common Stock
[F1][F5]2026-05-26$141.46/sh−1,519$214,872→ 489,872 total - Sale
Common Stock
[F1][F6]2026-05-26$142.35/sh−4,524$644,014→ 485,348 total - Sale
Common Stock
[F1][F7]2026-05-26$143.24/sh−6,055$867,338→ 479,293 total - Sale
Common Stock
[F1][F8]2026-05-26$144.13/sh−1,818$262,026→ 477,475 total
Footnotes (8)
- [F1]Represents the sale of shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $138.7700 to $139.7600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes 589 shares acquired under the Rocket Lab Corporation 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $139.8000 to $140.8000. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $140.8200 to $141.8200. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $141.8300 to $142.8300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $142.8400 to $143.8300. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $143.8500 to $144.7600. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
By: /s/ Arjun Kampani, as Attorney-in-Fact For: Marvin B. Clevenger|2026-05-28